Choate Investment Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-9,002
Closed -$224K 229
2018
Q3
$224K Sell
9,002
-1,258
-12% -$31.3K 0.01% 185
2018
Q2
$248K Buy
+10,260
New +$248K 0.01% 205